Literature DB >> 29807092

Elective distribution of resistance to beta-lactams among Enterobacter cloacae genetic clusters.

Simon Garinet1, Vincent Fihman2, Hervé Jacquier3, Stéphane Corvec4, Alban Le Monnier5, Thomas Guillard6, Vincent Cattoir7, Jean-Ralph Zahar8, Paul-Louis Woerther9, Etienne Carbonnelle10, Alain Wargnier11, Solen Kernéis12, Philippe C Morand13.   

Abstract

OBJECTIVES: The Enterobacter cloacae complex (Ecc), routinely referred to as "E. cloacae" in clinical microbiology, encompasses several species with 12 genetic clusters and one sequence crowd that can be identified based on hsp60 sequencing. Little is known about the pathogenicity and distribution of resistance to antibiotics among the Ecc. METHODS AND
RESULTS: In this prospective multicentre study, a total of 193 Ecc clinical isolates were collected from 10 academic hospitals distributed nationally across France and identified at the genetic cluster level on the basis of hsp60 sequencing. E. hormaechei isolates, which belong to clusters VI-VIII, were the largest group (53%), followed by cluster III that accounted for 28% of clinical isolates. All other Ecc clusters were present except cluster VII (E. hormaechei subsp. hormaechei). Cephalosporinase overproduction and ESBL were significantly more present in E. hormaechei (33% and 20%) than in other clusters (19% and 3%, respectively).
CONCLUSIONS: These results suggest that rapid identification of "E. cloacae" at the genetic cluster level could improve adequacy of empirical antibiotic treatment and reduce the unnecessary use of broad spectrum antibiotics.
Copyright © 2018 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29807092     DOI: 10.1016/j.jinf.2018.05.005

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  5 in total

1.  Dissemination of Extended-Spectrum-β-Lactamase-Producing Enterobacter cloacae Complex from a Hospital to the Nearby Environment in Guadeloupe (French West Indies): ST114 Lineage Coding for a Successful IncHI2/ST1 Plasmid.

Authors:  Matthieu Pot; Stéphanie Guyomard-Rabenirina; David Couvin; Célia Ducat; Vincent Enouf; Séverine Ferdinand; Gaëlle Gruel; Edith Malpote; Antoine Talarmin; Sébastien Breurec; Yann Reynaud
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

2.  Characterization of Enterobacter cloacae and Citrobacter freundii species complex isolates with decreased susceptibility to cephalosporins from United States hospitals and activity of ceftazidime/avibactam and comparator agents.

Authors:  Helio S Sader; Rodrigo E Mendes; Timothy B Doyle; Andrew P Davis; Mariana Castanheira
Journal:  JAC Antimicrob Resist       Date:  2021-08-20

3.  Revisiting Species Identification within the Enterobacter cloacae Complex by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.

Authors:  Alexandre Godmer; Yahia Benzerara; Anne Cécile Normand; Nicolas Veziris; Salah Gallah; Catherine Eckert; Philipe Morand; Renaud Piarroux; Alexandra Aubry
Journal:  Microbiol Spectr       Date:  2021-08-11

4.  Cluster Differences in Antibiotic Resistance, Biofilm Formation, Mobility, and Virulence of Clinical Enterobacter cloacae Complex.

Authors:  Shixing Liu; Liqiong Chen; Lingbo Wang; Beibei Zhou; Dandan Ye; Xiangkuo Zheng; Yishuai Lin; Weiliang Zeng; Tieli Zhou; Jianzhong Ye
Journal:  Front Microbiol       Date:  2022-04-06       Impact factor: 5.640

5.  Wide Distribution and Specific Resistance Pattern to Third-Generation Cephalosporins of Enterobacter cloacae Complex Members in Humans and in the Environment in Guadeloupe (French West Indies).

Authors:  Matthieu Pot; Yann Reynaud; David Couvin; Célia Ducat; Séverine Ferdinand; François Gravey; Gaëlle Gruel; François Guérin; Edith Malpote; Sébastien Breurec; Antoine Talarmin; Stéphanie Guyomard-Rabenirina
Journal:  Front Microbiol       Date:  2021-06-25       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.